您的位置: 首页 > 农业专利 > 详情页

NOUVEAU DERIVE DE PYRIMIDINE AYANT POUR EFFET D'INHIBER LA CROISSANCE DE CELLULES CANCEREUSES, ET COMPOSITION PHARMACEUTIQUE CONTENANT CELUI-CI
专利权人:
LTD.;ONCOBIX CO.
发明人:
KIM, SUNG-EUN,LEE, SUNHO,RAJESH, RENGASAMY,KANG, DAE HO,RYU, HYUNG CHUL,KIM, JAE-SUN,LEE, SANGRYUL,KIM, KYONG CHEOL,RHO, JIN KYUNG,LEE, JAE CHEOL
申请号:
CA3083933
公开号:
CA3083933A1
申请日:
2018.12.06
申请国别(地区):
CA
年份:
2019
代理人:
摘要:
The present invention provides a novel pyrimidine derivative compound and a salt thereof. The pyrimidine derivative compound effectively inhibits the growth of cancer cells in which c797s-mutated EGFR expression and MET amplification, which are major resistance mechanisms of third generation EGFR anticancer drugs, have occurred, thereby being effectively usable in the treatment of lung cancer.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充